KUBASIK CHRISTOPHER E

CEO Christopher Kubasik sells full LHX position: 14,171 shares at $301.05 for $4.3M, exiting completely.

Christopher Kubasik, Chair and CEO of L3Harris Technologies, liquidated his entire remaining shareholding of 14,171 shares on 2025-11-13 at $301.05 for a total value of $4,266,179.55, leaving him with zero shares post-transaction. The sale came near the 52-week high of $306.76 (stock currently at $289.39, down 5.7% from that peak), and the timing stands in contrast to his broader pattern: across his cross-ticker history, his 11 prior sells averaged +4.6% returns over 90 days (poorly timed, as the stock typically rose after his sales), but at LHX specifically, zero of his four prior measurable 90-day outcomes were well-timed (all showed positive returns). The company fundamentals remain solid with FY revenue growth of +9.8%, net income of $462.0M on $5.7B quarterly revenue, and a market cap of $54.1B, though the P/E of 36.59 reflects premium valuation. A CEO's complete exit from personal holdings merits attention given the concentrated departure and the contrast between execution timing near recent highs and a historical pattern of poor sell timing at this ticker.

LHX CEO KUBASIK sells 83,000 shares (-36.3% of holdings) for $23.2M at $279.90, near 52-week high.

KUBASIK CHRISTOPHER E, Chair and CEO, sold 83,000 shares of L3HARRIS TECHNOLOGIES at $279.90 on 2025-09-12, reducing his holdings from 228,577 to 145,577 shares and representing a -36.3% reduction in his pre-transaction position. The sale price of $279.90 places the transaction just 0.5% below the 52-week high of $280.63, and coincides with a strong recent momentum window (30-day change: +3.3%, 90-day change: +8.6%). At the same ticker, his prior five open-market sales show mixed timing: two recent sales on 2025-08-11 and 2025-07-29 show modest positive 30-day returns (+2.3%, +2.2%), two earlier sales on 2025-06-11 and 2025-06-12 exhibited stronger gains (+5.1%, +4.5%), but his 2024-10-31 sale resulted in a -14.6% 90-day decline, indicating one of three measured same-ticker outcomes was well-timed. His cross-ticker track record of 10 prior sells carries an avg 90d return of +3.8% (poorly timed), with only 12.50% of those sales proving well-timed at the 90-day mark. The company's fundamentals remain solid: $5.4B latest quarterly revenue, +9.8% annual growth, $458.0M net income, and $52.2B market cap; however, the P/E of 30.78 reflects current valuation levels.

CEO Kubasik sold 40,138 shares of LHX at $269.52 for $10.8M; holdings down 21.6% to 145.6K shares

Christopher E. Kubasik, Chair and CEO, sold 40,138 shares at $269.52 on 2025-08-11, reducing his post-transaction holdings to 145,577 shares (145.6K shares), a 21.6% reduction from his prior 185,715 shares (185.7K shares). The sale occurred at a price $0.69 below the current market price of $270.21 and near the stock's 52-week high of $278.26 (approximately -2.9% from that peak). His same-ticker sell history at LHX shows mixed timing: the 2024-10-31 sale resulted in a -14.6% 90-day return (well-timed), while the 2024-06-04 sale saw a +4.9% 90-day return (poorly-timed). His cross-ticker track record shows 9 prior sells with a 16.67% well-timed rate and +1.7% average 90-day return, indicating historically weak timing on the sell side. The company fundamentals remain solid: $5.4B quarterly revenue, +9.8% annual growth, and $50.6B market cap, though the P/E of 29.79 reflects a premium valuation.

CEO Christopher Kubasik sold 72,000 LHX shares at $271.14 for $19.5M, reducing stake by 33.1% to 145,577 shares post-transaction.

Christopher E Kubasik, Chair and CEO of L3Harris Technologies, divested 72,000 shares at $271.14 on 2025-07-29, representing a significant 33.1% reduction of his pre-transaction holdings. The transaction occurred near the company's 52-week high of $273.22 (-0.3%), with the stock up 10.3% over 30 days and 23.8% over 90 days, signaling strong recent momentum at the point of sale. His cross-ticker track record shows modest sell timing—only 16.67% of his prior sells were well-timed (stock declined post-sale), with average 90d returns of +1.7%, meaning his cross-ticker sells generally preceded stock gains. At LHX specifically, his prior five trades show mixed outcomes: two recent June 2025 sales registered +4.5% and +5.1% 30-day returns, but his October 2024 sale was followed by a -14.6% 90-day decline—only 1 of 3 measurable prior LHX sales was well-timed. L3Harris fundamentals remain solid with $5.4B quarterly revenue and +9.8% annual growth, though the stock trades at a P/E of 30.02, in line with the high valuation context at the transaction date.

LHX CEO Christopher Kubasik sold 35,273 shares ($8.8M) across two transactions at $247.01–$248.48

Christopher Kubasik (Chair and CEO) executed two separate sales on 2025-06-11 and 2025-06-12, selling 2,212 shares at $247.01 and 33,061 shares at $248.48 for a combined $8,761,383.40 at a blended average price of $248.39. This represents a 19.5% reduction in his holdings (from 180,845 to 145,572 shares), a substantial portfolio reduction by the sitting CEO. The sales occurred after a strong 30-day (+17.0%) and 90-day (+21.8%) rally in LHX stock, and current price stands at $256.99, above both transaction prices. Against Kubasik's own cross-ticker track record, his prior six open-market sells averaged +1.7% 90-day returns (poorly timed overall, with only 16.67% well-timed rate); his five prior sales at LHX specifically showed just 1 of 5 well-timed at the 90-day mark. The scale and execution of this sale—particularly the large second tranche of 33,061 shares—warrants attention given the CEO's position and the context of recent equity strength.

LHX CEO KUBASIK sold 21,351 shares at $248.11 on 2024-10-31 for $5,297,396.61; holds 130,506 shares post-transaction.

KUBASIK CHRISTOPHER E, Chair and CEO of L3HARRIS TECHNOLOGIES, sold 21,351 shares at $248.11, reducing his holdings by 21,351 shares or 14.1% from pre-transaction levels. His prior trades at LHX show an unfavorable timing pattern: all 5 prior sales at this ticker have resulted in positive 90-day returns (ranging from +2.0% to +6.4%), meaning the insider sold and the stock subsequently rose—poorly-timed exits by the timing metric. The current transaction occurred near the 52-week high ($252.81), with the stock at $247.07 today and up 9.3% over the past 90 days, continuing the trend of post-sale appreciation seen in his historical trades at this ticker. The sale size and valuation (P/E of 38.85, with recent quarterly revenue of $5,292,000,000.00 and net income of $400,000,000.00) merit monitoring but do not by themselves signal material strategic repositioning.